In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities. The public and the pharmaceutical industry are placing ...

Polymorphism is common in all organic molecules, forming more than one unique crystalline forms called polymorphs. This phenomenon is gaining traction especially in the pharmaceutical industry owing ...

Polymorphism — the existence of different crystal structures of the same compound — is a problem in the pharmaceutical industry, because different polymorphs of the same drug may have different ...